Gentamicin
Small molecule targets CFTR via restoration
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | GARAMYCIN | — | 1966-03-15 | fda.gov ↗ |
Trials 120 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT07643974 | Jun 2026 → Sep 2027 expected | multiple sclerosis, spina bifida, spinal cord injury, urinary bladder disorder +1 | Medstar Health Research Institute | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT01633762 | Apr 2012 → Apr 2013 | diabetes mellitus, obesity disorder, osteoporosis | University Hospital, Gentofte, Copenhagen | Completed | No outcome recorded |
| Phase 0 | NCT01878643 | Dec 2001 → Dec 2002 | primary bacterial infectious disease, respiratory failure, respiratory tract infectious disorder | Stony Brook University | Completed | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT04544943 | May 2021 → Sep 2022 | atopic eczema | Hoth Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT04967859 | Jul 2018 → Nov 2019 | — | São Paulo State University | Completed | No outcome recorded |
| Phase 1 | NCT02515448 | Oct 2015 → Nov 2016 | — | Poitiers University Hospital | Completed | No outcome recorded |
| Phase 1 | NCT00451074 | Mar 2007 → Jul 2009 | Duchenne muscular dystrophy | Nationwide Children's Hospital | Completed | No outcome recorded |
| Phase 1 | NCT00005574 | Feb 2000 → Jan 2001 | Becker muscular dystrophy, Duchenne muscular dystrophy | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 1/27 trials · 1 met primary | ||||||
| Phase 1/2 | NCT04644627 | Dec 2020 → Jan 2022 | epidermolysis bullosa | Oslo University Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT04140786 | Oct 2019 → Nov 2023 | junctional epidermolysis bullosa Herlitz type | University of Southern California | Unknown | No outcome recorded |
| Phase 1/2 | NCT03392909 | Jul 2018 → Dec 2023 | recessive dystrophic epidermolysis bullosa | University of Southern California | Unknown | No outcome recorded |
| Phase 1/2 | NCT03526159 | Jun 2018 → Jul 2020 overdue | junctional epidermolysis bullosa Herlitz type | University of Southern California | Recruiting | No outcome recorded |
| Phase 1/2 | NCT03012191 | Feb 2017 → May 2018 | recessive dystrophic epidermolysis bullosa | University of Southern California | Completed | No outcome recorded |
| Phase 1/2 | NCT02698735 | Feb 2016 → Mar 2017 | recessive dystrophic epidermolysis bullosa | University of Southern California | Completed | Met primary |
| Phase 1/2 | NCT02036528 | Jan → Dec 2014 | ulcer of lower limbs | Royer Biomedical, Inc. | Terminated | No outcome recorded |
| Phase 224 trials · 1 met primary | ||||||
| Phase 2 | NCT06007352 | Oct 2024 → Oct 2025 | infectious disease with sepsis, urinary tract infection | Yale University | Withdrawn | No outcome recorded Stop: Business |
| Phase 2 | NCT06362447 | Sep 2024 → Apr 2026 overdue | ichthyosis | University Hospital, Toulouse | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07407491 | Jul 2024 → Jul 2026 overdue | acute cholangitis, biliary tract cancer, choledocholithiasis | National University of Malaysia | Recruiting | No outcome recorded |
| Phase 2 | NCT05303909 | May 2022 → May 2024 | — | Singapore General Hospital | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT05287425 | Aug 2019 → Aug 2023 | — | Medical University of Vienna | Completed | No outcome recorded |
| Phase 2 | NCT04039750 | Jul 2019 → Dec 2026 expected | appendicitis | Prisma Health-Upstate | Active not recruiting | No outcome recorded |
| Phase 2 | NCT03476941 | Apr 2019 → Oct 2020 | abscess | University of Iowa | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03931408 | Feb 2019 → Jul 2020 | spinal cord injury | University of Louisville | Completed | No outcome recorded |
| Phase 2 | NCT03778008 | Dec 2018 → Dec 2019 | stomatitis | Second Affiliated Hospital of Nanchang University | Unknown | No outcome recorded |
| Phase 2 | NCT02784821 | Jan 2017 → Sep 2019 | bacterial infectious disease, bronchopulmonary dysplasia, intestinal perforation, intracerebral hemorrhage +3 | University of Florida | Completed | No outcome recorded |
| Phase 2 | NCT02577393 | Apr 2015 → Jun 2022 | esophagitis, lung neoplasm | Shandong Cancer Hospital and Institute | Unknown | No outcome recorded |
| Phase 2 | NCT01140191 | Sep → Dec 2013 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01988909 | Sep 2013 → Dec 2015 | cutaneous leishmaniasis | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 2 | NCT01494350 | Dec 2011 → Jun 2012 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Terminated | No outcome recorded |
| Phase 2 | NCT01570192 | Sep 2010 → Apr 2015 | bacterial pneumonia | University of Florida | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00659646 | Apr 2008 → May 2009 | ulcer of lower limbs | Innocoll | Completed | No outcome recorded |
| Phase 2 | NCT00658957 | Apr 2008 → Oct 2009 | ulcer of lower limbs | Innocoll | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT00593567 | Dec 2007 → May 2009 | ulcer of lower limbs | Innocoll | Completed | No outcome recorded |
| Phase 2 | NCT00657917 | Dec 2006 → Jun 2007 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00317070 | Apr 2006 → Feb 2009 | interstitial cystitis | Nova Scotia Health Authority | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01536795 | Oct 2005 → Feb 2007 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 2 | NCT00396578 | Aug 2003 → Sep 2004 | respiratory tract infectious disorder, tracheobronchitis | Stony Brook University | Completed | No outcome recorded |
| Phase 2 | NCT00703924 | Mar 2003 → Nov 2004 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | Met primary |
| Phase 2 | NCT00376428 | Jan 2003 → Jun 2005 | cystic fibrosis | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 2/34 trials · 1 met primary | ||||||
| Phase 2/3 | NCT04238923 | May 2020 → May 2021 | peripheral vascular disease | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Unknown | No outcome recorded |
| Phase 2/3 | NCT03632109 | Sep 2018 → Mar 2019 | gonorrhea | University of Washington | Terminated | No outcome recorded |
| Phase 2/3 | NCT03503513 | Aug 2018 → Sep 2023 | spinal cord injury, urinary tract infection | University of Michigan | Completed | Met primary |
| Phase 2/3 | NCT00128466 | Aug 2004 → Feb 2007 | plague | Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 324 trials · 3 met primary · 2 missed | ||||||
| Phase 3 | NCT06841003 | Feb 2025 → Jun 2027 expected | abscess, appendicitis | Spaarne Gasthuis | Recruiting | No outcome recorded |
| Phase 3 | NCT06387147 | Jan 2025 → Nov 2027 expected | acute intestinal ischemia | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase 3 | NCT05766670 | Apr 2024 → Jan 2027 expected | osteomyelitis | Wake Forest University Health Sciences | Recruiting | No outcome recorded |
| Phase 3 | NCT05502380 | Sep 2022 → Dec 2024 overdue | bacterial infectious disease | Balgrist University Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT04731025 | Jan 2021 → Sep 2026 overdue | breast disorder, poisoning, prosthesis-related infectious disease | Mikkel Herly | Active not recruiting | No outcome recorded |
| Phase 3 | NCT04110340 | Feb 2020 → Apr 2024 | bubonic plague, pneumonic plague | University of Oxford | Completed | Met primary |
| Phase 3 | NCT04041791 | Aug 2019 → Apr 2024 | pneumonia | University of Oxford | Completed | No outcome recorded |
| Phase 3 | NCT03491540 | Sep 2018 → Oct 2023 | rectal cancer | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT03475680 | Aug 2018 → Aug 2021 | colon carcinoma | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 3 | NCT03303677 | Apr → Nov 2018 | chronic rhinosinusitis | University of Florida | Withdrawn | No outcome recorded |
| Phase 3 | NCT03294395 | Sep 2017 → Jun 2020 | gonorrhea | Public Health Service of Amsterdam | Completed | Mixed |
| Phase 3 | NCT03132116 | May 2017 → Aug 2025 | cat-scratch disease | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 3 | NCT03081962 | Feb → Aug 2017 | — | Hospital General Universitario Elche | Unknown | No outcome recorded |
| Phase 3 | NCT02447172 | Jun 2015 → Sep 2016 | infectious disease, ulcer of lower limbs | Innocoll | Completed | No outcome recorded |
| Phase 3 | NCT02427802 | May 2015 → Oct 2016 | chronic ulcer of skin, skin infection | Innocoll | Completed | No outcome recorded |
| Phase 3 | NCT02479971 | Jan 2014 → Jun 2015 | — | Hospital General Universitario Elche | Completed | No outcome recorded |
| Phase 3 | NCT01790659 | May 2013 → Jan 2016 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 3 | NCT02314806 | Jan 2013 → Dec 2014 | breast cancer | Hospital General Universitario Elche | Completed | No outcome recorded |
| Phase 3 | NCT01667874 | Jan 2013 → Sep 2016 | infectious disease | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT01700504 | May 2011 → Sep 2012 | — | Hospital General Universitario Elche | Completed | Met primary |
| Phase 3 | NCT00600925 | Jan 2008 → Mar 2009 | — | Innocoll | Completed | Missed primary |
| Phase 3 | NCT00606580 | Jan 2008 → Jul 2011 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | Met primary |
| Phase 3 | NCT00600483 | Dec 2007 → Sep 2010 | — | Innocoll | Completed | Missed primary |
| Phase 3 | NCT00189384 | Nov 2003 → Dec 2005 | bacterial infectious disease with sepsis | Aga Khan University | Unknown | No outcome recorded |
| Phase 432 trials · 2 met primary · 1 missed | ||||||
| Phase 4 | NCT07563504 | Jul 2026 → Jan 2027 expected | — | Sarawak General Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07220967 | Oct 2025 → Oct 2027 expected | breast cancer | Memorial Sloan Kettering Cancer Center | Recruiting | No outcome recorded |
| Phase 4 | NCT06332781 | Apr → Sep 2025 | urinary tract infection | Women and Infants Hospital of Rhode Island | Completed | No outcome recorded |
| Phase 4 | NCT06209047 | Oct 2023 → May 2026 overdue | bronchiectasis | Assiut University | Recruiting | No outcome recorded |
| Phase 4 | NCT06332040 | Oct 2023 → Oct 2026 expected | urinary tract infection | St. Joseph's Hospital and Medical Center, Phoenix | Recruiting | No outcome recorded |
| Phase 4 | NCT05862402 | May 2023 → May 2024 | Klebsiella pneumonia | Phramongkutklao College of Medicine and Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05157126 | Sep 2022 → Apr 2028 expected | — | University of California, San Francisco | Recruiting | No outcome recorded |
| Phase 4 | NCT04876131 | May 2022 → Jan 2028 expected | urinary tract infection | Murdoch Childrens Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT04753723 | Feb → Nov 2021 | skin infection | The Metis Foundation | Completed | No outcome recorded |
| Phase 4 | NCT03483363 | Oct 2018 → Jan 2022 | — | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02848820 | Dec 2016 → Dec 2024 | appendicitis | Ramon Gorter | Unknown | Missed primary |
| Phase 4 | NCT02415257 | Apr 2015 → Sep 2020 | acoustic neuroma | Lund University | Withdrawn | No outcome recorded |
| Phase 4 | NCT02423759 | Apr 2015 → Jan 2017 | benign prostatic hyperplasia | Mansoura University | Completed | No outcome recorded |
| Phase 4 | NCT02379754 | Jan 2015 → Jun 2019 | acoustic neuroma | Lund University | Withdrawn | No outcome recorded |
| Phase 4 | NCT02898961 | Oct 2014 → Dec 2016 | infectious disease with sepsis | Nîmes University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02926846 | Mar 2014 → Nov 2017 | kidney failure, peritonitis | Alice Ho Miu Ling Nethersole Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01982864 | Oct 2013 → Jan 2016 | end stage renal failure | University Hospital, Limoges | Terminated | No outcome recorded |
| Phase 4 | NCT01951768 | Sep 2013 → Jun 2016 | ulcer of lower limbs | University Hospital, Geneva | Completed | No outcome recorded |
| Phase 4 | NCT01884467 | May 2013 → Dec 2015 | urinary tract infection | Gillette Children's Specialty Healthcare | Unknown | No outcome recorded |
| Phase 4 | NCT01585129 | Sep 2010 → Jul 2014 | — | Washington University School of Medicine | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00926796 | Jun 2010 → Dec 2012 | gonorrhea | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 4 | NCT01247909 | Apr 2010 → Feb 2015 | bacterial meningitis | Kamuzu University of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT00671528 | Jul 2009 → May 2010 | atopic eczema | Organon and Co | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00638157 | Feb 2009 → Nov 2011 | infective endocarditis | Merck & Co., Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT00751374 | Sep 2008 → Oct 2014 | mycobacterial infectious disease | Kwong Wah Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01678365 | Jul 2008 → Oct 2009 | appendicitis | HaEmek Medical Center, Israel | Completed | No outcome recorded |
| Phase 4 | NCT00480376 | Jun 2007 → Mar 2008 | infectious disease | HaEmek Medical Center, Israel | Unknown | No outcome recorded |
| Phase 4 | NCT00671541 | Mar 2006 → Feb 2012 | chronic rhinosinusitis | Lahey Clinic | Withdrawn | No outcome recorded |
| Phase 4 | NCT00304811 | Jan 2006 → Jan 2007 | staphylococcus aureus infection | Michael E. DeBakey VA Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT00294502 | Sep 2003 → May 2004 | end stage renal failure | Henry Ford Health System | Completed | Met primary |
| Phase 4 | NCT00198601 | Aug 2003 → Jul 2005 | infectious disease | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| Phase 4 | NCT00398658 | Mar 2002 → Dec 2004 | endophthalmitis | Shahid Beheshti University of Medical Sciences | Completed | Met primary |
| Phase not applicable21 trials · 1 met primary | ||||||
| — | NCT07655050 | Jun 2026 → Feb 2027 expected | nephrolithiasis, urinary tract infection | Hitit University | Recruiting | No outcome recorded |
| — | NCT07311395 | Dec 2025 → Jan 2027 expected | — | Western Galilee Hospital-Nahariya | Recruiting | No outcome recorded |
| — | NCT07478874 | Jul → Dec 2025 | — | Lahore General Hospital | Completed | No outcome recorded |
| — | NCT07704398 | Oct 2023 → Apr 2026 | periapical periodontitis | Istanbul Medipol University Hospital | Completed | No outcome recorded |
| — | NCT05750966 | Jul 2023 → Apr 2026 | cholangitis | Academic Medical Center - University of Amsterdam | Completed | No outcome recorded |
| — | NCT05251584 | Dec 2021 → Mar 2023 | infectious peritonitis | Phramongkutklao College of Medicine and Hospital | Unknown | No outcome recorded |
| — | NCT04839653 | May 2021 → Apr 2022 | acute respiratory distress syndrome, bacterial infectious disease, infectious disease with sepsis, pneumonia | MEDSI Clinical Hospital 1, ICU | Unknown | No outcome recorded |
| — | NCT05355610 | Apr 2021 → Apr 2022 | vestibular disorder | Combined Military Hospital Quetta | Unknown | No outcome recorded |
| — | NCT06454643 | Jan 2020 → Jan 2021 | — | Al-Rasheed University College | Completed | Mixed |
| — | NCT03559400 | Nov 2019 → Sep 2021 | — | University of California, San Francisco | Completed | No outcome recorded |
| — | NCT03688659 | Jan 2019 → Jan 2021 | infective endocarditis | Assiut University | Unknown | No outcome recorded |
| — | NCT03157388 | Jun 2017 → Jun 2018 | alcoholic hepatitis | University of Aarhus | Completed | No outcome recorded |
| — | NCT02033408 | Jan 2014 → Dec 2018 | Crohn's colitis, ulcerative colitis | Shaare Zedek Medical Center | Completed | Met primary |
| — | NCT02963896 | Jan 2014 → Dec 2015 | acoustic neuroma | University Hospital, Motol | Completed | No outcome recorded |
| — | NCT01785641 | Dec 2012 → Dec 2013 | peritonitis | Chulalongkorn University | Completed | No outcome recorded |
| — | NCT01356641 | Sep 2012 → Jan 2017 | appendicitis | Ramon R. Gorter | Completed | No outcome recorded |
| — | NCT01153191 | Aug 2010 → Sep 2012 | infectious disease | Dallas VA Medical Center | Unknown | No outcome recorded |
| — | NCT00669799 | Mar 2008 → Jan 2010 | sinusitis | University of South Florida | Withdrawn | No outcome recorded |
| — | NCT00596167 | Sep 2007 → Apr 2009 | end stage renal failure, infectious disease | Indiana University | Completed | No outcome recorded |
| — | NCT00490230 | Apr → Jun 2007 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| — | NCT00465530 | Mar 2007 → Mar 2010 | sinusitis | Julie Wei, MD | Completed | No outcome recorded |
| Comparator or background therapy66 trials | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT03213249 Comparator | Jul 2017 → Sep 2018 | breast disorder | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT06428448 Background | Feb 2026 → Aug 2027 expected | periprosthetic joint infection | OsteoRemedies, LLC | Recruiting | No outcome recorded |
| Phase 2 | NCT05702762 Comparator | Oct 2022 → Jun 2023 | cystitis | Mercy Health Ohio | Unknown | No outcome recorded |
| Phase 2 | NCT04246996 Comparator | Jan 2020 → Dec 2021 | female stress incontinence, pelvic organ prolapse, urinary tract infection | Kaiser Permanente | Completed | No outcome recorded |
| Phase 2 | NCT03492866 Comparator | Apr 2018 → Feb 2019 | hypotrichosis simplex | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT03453177 Background | Mar 2018 → Mar 2019 | neonatal sepsis | Drugs for Neglected Diseases | Completed | No outcome recorded |
| Phase 2 | NCT02735317 Comparator | Apr 2016 → Jun 2017 | nasopharyngeal neoplasm, stomatitis | Yun-fei Xia | Unknown | No outcome recorded |
| Phase 2 | NCT01083576 Comparator | Mar 2010 → Jun 2011 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 2 | NCT01032382 Comparator | Jan 2010 → Mar 2011 | cutaneous leishmaniasis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 2/3 | NCT05051163 Comparator | Jun 2021 → Jun 2024 | HIV infectious disease, protein-energy malnutrition | Makerere University | Unknown | No outcome recorded |
| Phase 2/3 | NCT03622450 Comparator | Jan 2016 → Jan 2018 | — | Nourhan Hassan Osama Thuraya Mohamed | Completed | No outcome recorded |
| Phase 2/3 | NCT01931592 Comparator | Jan 2014 → Oct 2016 | cancer | Maria J.G.T. Vehreschild | Terminated | No outcome recorded |
| Phase 2/3 | NCT01994993 Comparator | Dec 2013 → Jan 2017 | — | Michael Cohen-Wolkowiez | Completed | No outcome recorded |
| Phase 2/3 | NCT00879190 Comparator | May 2009 → Jun 2012 | chorioamnionitis | Stanford University | Completed | No outcome recorded |
| Phase 2/3 | NCT00802529 Comparator | Apr 2009 → May 2015 | Meniere disease | Imperial College London | Completed | Missed primary |
| Phase 2/3 | NCT01633294 Comparator | Oct 2008 → Jan 2011 | chorioamnionitis, endometritis, infectious meningitis, neonatal sepsis | Hospital de Santa Maria, Portugal | Completed | No outcome recorded |
| Phase 2/3 | NCT01244256 Background | Apr → Aug 2007 | folliculitis | Azidus Brasil | Suspended | No outcome recorded |
| Phase 3 | NCT07107477 Comparator | May 2025 → Sep 2027 expected | preterm premature rupture of the membranes | The Central and Eastern European Gynecologic Oncology Group | Recruiting | No outcome recorded |
| Phase 3 | NCT05977400 Comparator | Apr 2024 → Mar 2029 expected | neurodevelopmental disorder | Sharp HealthCare | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06489431 Comparator | Dec 2023 → May 2026 overdue | erectile dysfunction, prosthesis-related infectious disease | Rush University Medical Center | Active not recruiting | Met primary |
| Phase 3 | NCT05658874 Background | Dec 2022 → Dec 2024 | interstitial cystitis, levator syndrome | Jocelyn Fitzgerald | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT05594472 Comparator | Nov 2022 → Apr 2023 | bullous pemphigoid, pemphigus vulgaris | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT05429671 Comparator | Jun 2022 → Nov 2023 | — | Rothman Institute Orthopaedics | Completed | No outcome recorded |
| Phase 3 | NCT05164081 Background | Jan 2022 → Jan 2026 overdue | periprosthetic joint infection | Umeå University | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03174236 Comparator | Sep 2017 → Jan 2020 | poisoning, protein-energy malnutrition | University of Oxford | Unknown | No outcome recorded |
| Phase 3 | NCT02717871 Comparator | Mar 2016 → Oct 2020 | keratitis | University Hospital, Geneva | Completed | No outcome recorded |
| Phase 3 | NCT02579161 Comparator | Sep 2014 → Mar 2018 | urolithiasis | Northwell Health | Completed | No outcome recorded |
| Phase 3 | NCT01551394 Comparator | Sep 2012 → Dec 2014 | infectious disease with sepsis | PENTA Foundation | Completed | No outcome recorded |
| Phase 3 | NCT01429701 Comparator | May → Jun 2012 | dermatitis | EMS | Completed | No outcome recorded |
| Phase 3 | NCT01027429 Comparator | Dec 2009 → Dec 2013 | neonatal sepsis | Aga Khan University | Completed | Met primary |
| Phase 4 | NCT06712641 Comparator | Apr 2026 → Jun 2028 expected | infectious disease with sepsis | University Hospital, Akershus | Recruiting | No outcome recorded |
| Phase 4 | NCT07236944 Comparator | Dec 2025 → Mar 2029 expected | bacterial urinary tract infection | Uppsala University | Recruiting | No outcome recorded |
| Phase 4 | NCT06814223 Comparator | Oct 2024 → Dec 2027 expected | prosthesis-related infectious disease | Western Galilee Hospital-Nahariya | Recruiting | No outcome recorded |
| Phase 4 | NCT05971537 Comparator | Jun 2023 → Oct 2026 expected | infectious peritonitis | Alice Ho Miu Ling Nethersole Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT05421741 Comparator | May 2023 → Dec 2026 expected | osteomyelitis | Wake Forest University Health Sciences | Recruiting | No outcome recorded |
| Phase 4 | NCT04285320 Comparator | Mar 2021 → Apr 2023 | urinary tract infection | Atlantic Health System | Unknown | No outcome recorded |
| Phase 4 | NCT03997266 Comparator | Aug 2020 → Jan 2026 | neonatal sepsis, perinatal necrotizing enterocolitis | Michael Morowitz | Completed | No outcome recorded |
| Phase 4 | NCT03560232 Comparator | Jul 2018 → Feb 2020 | — | Mercy Health Ohio | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03299387 Comparator | Jun 2017 → Jul 2018 | urinary tract infection | Mayo Clinic | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02582099 Comparator | Jan 2017 → Jun 2019 | sinusitis | Mahidol University | Unknown | No outcome recorded |
| Phase 4 | NCT03007225 Comparator | Jul 2015 → Aug 2016 | hepatocellular carcinoma | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT02384200 Background | Mar 2015 → Feb 2017 | nephrolithiasis, urinary tract infection | University of California, San Diego | Completed | No outcome recorded |
| Phase 4 | NCT02309346 Background | Dec 2014 → Dec 2023 | uterine disorder | Hospital de Clinicas de Porto Alegre | Completed | No outcome recorded |
| Phase 4 | NCT01659866 Comparator | Aug 2012 → Aug 2015 | infectious disease | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT01273818 Comparator | Jan 2011 → Feb 2013 | — | Diskapi Teaching and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00749866 Comparator | May 2007 → Aug 2009 | bronchiectasis | University of Edinburgh | Completed | No outcome recorded |
| Phase 4 | NCT00571259 Comparator | Sep 2003 → Jan 2010 | bacterial infectious disease | Satellite Healthcare | Completed | No outcome recorded |
| — | NCT06168708 Comparator | Dec 2023 → Jun 2024 | — | Tanta University | Unknown | No outcome recorded |
| — | NCT05469984 Comparator | Nov 2022 → Sep 2025 overdue | preterm premature rupture of the membranes | Western Galilee Hospital-Nahariya | Recruiting | No outcome recorded |
| — | NCT05143164 Comparator | Mar 2022 → Jul 2025 | — | Singapore General Hospital | Completed | No outcome recorded |
| — | NCT04438655 Background | May 2019 → Nov 2021 | — | University of Turin, Italy | Completed | No outcome recorded |
| — | NCT02865564 Comparator | Nov 2016 → Mar 2020 | digestive system disorder | University Medical Centre Ljubljana | Completed | No outcome recorded |
| — | NCT02829060 Comparator | Jan 2016 → Jan 2025 | infectious disease with sepsis, nephrolithiasis, urinary tract infection | University of California, San Diego | Completed | No outcome recorded |
| — | NCT02395614 Comparator | Dec 2015 → Dec 2020 | breast cancer | Vanderbilt University Medical Center | Completed | No outcome recorded |
| — | NCT02477423 Comparator | Jul 2015 → Jun 2019 | perinatal necrotizing enterocolitis, pulmonary immaturity | University of Chicago | Completed | No outcome recorded |
| — | NCT02288923 Comparator | Mar 2015 → Jul 2018 | osteoarthritis, knee | Royal Devon and Exeter NHS Foundation Trust | Completed | No outcome recorded |
| — | NCT01945450 Comparator | Jan 2014 → Sep 2016 | endometritis | Hadassah Medical Organization | Unknown | No outcome recorded |
| — | NCT01372371 Comparator | Jun 2011 → Jun 2012 | infectious disease | Ganga Hospital | Unknown | No outcome recorded |
| — | NCT01148693 Comparator | Dec 2009 → Dec 2010 | cholangitis | Tehran University of Medical Sciences | Completed | No outcome recorded |
| — | NCT01266499 Comparator | Jul 2009 → Jan 2011 | Klebsiella infectious disease | Rambam Health Care Campus | Completed | No outcome recorded |
| — | NCT00844337 Comparator | Mar 2009 → Sep 2013 | infectious disease with sepsis | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| — | NCT00814905 Comparator | Nov 2008 → Jan 2012 | chorioamnionitis | United States Naval Medical Center, Portsmouth | Withdrawn | No outcome recorded |
| — | NCT00753558 Comparator | Nov 2008 → Jun 2010 | — | Soroka University Medical Center | Completed | No outcome recorded |
| — | NCT00484055 Comparator | Jan 2007 → Aug 2008 | drug-resistant tuberculosis, periprosthetic joint infection | Region Örebro County | Completed | No outcome recorded |
| — | NCT00185991 Comparator | Jun 2004 → Oct 2006 | chorioamnionitis | Stanford University | Completed | No outcome recorded |
Evidence & citations 19 cited values
Every value below carries the sentence it was read from. 187 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gentamicin | “Each subject will receive a single dose of 15 mg/kg vancomycin; 2 mg/kg gentamicin and 250 mg levofloxacin administered intravenously over a one-hour infusion period through...” NCT00596167 ↗163“Some commonly used antibiotics for the treatment of PD peritonitis with their suggested concentrations in the antibiotic-lock are quoted as below: Cefazolin 10mg/mL...” NCT05971537 ↗ “Assessment of Cutaneous Leishmaniasis Scar (Caused by Leishmania Major) for Cosmetic Outcome After Treatment With WR279396 (Paromomycin/Gentamicin Cream in Vehicle) Versus a No...” NCT00490230 ↗ “A sample of 802 ELBW preterm infants will undergo web-based stratified block randomization to receive empiric antibiotics (EA; ampicillin and gentamicin) or placebo during...” PMID 35606829 ↗ May 2022 “Antibiotics: Ceftazidime-Avibactam or Combination antibiotics (eg. Meropenem-Colistin, Imipenem-Colistin, Tigecycline-Amikacin, Tigecycline-Gentamicin, Tigecycline-Meropenem or...” NCT05862402 ↗ “Participants were randomly assigned into two groups: a standard root canal treatment group (n = 40) and an adjunctive treatment group receiving submucosal betamethasone and...” NCT07704398 ↗ “WR 279,396 is a topical antibiotic cream containing paromomycin and gentamicin that will be applied to each lesion once a day for 20 days and covered with a sterile gauze and...” NCT01494350 ↗ “OBJECTIVE: To evaluate the efficacy of intraocular gentamicin sulfate and clindamycin in the prevention of acute posttraumatic bacterial endophthalmitis following penetrating...” PMID 17420365 ↗ Apr 2007 “WR 279,396 is a topical antibiotic cream containing 15% paromomycin and 0.5% gentamicin that will be applied to each lesion once a day and covered with a steril” NCT00606580 ↗ “Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.” PMID 12138146 ↗ Aug 2002 “ampicillin 50mg/kg twice daily and gentamicin \[3mg/kg for babies \<2kg or 5mg/kg for babies \>2kg\] once daily for 7 days, as per Kenyan guidelines).” NCT03453177 ↗ |
| Known as | AppliGel-G | “AppliGel-G is a topically applied hydrogel formulation of gentamicin sulfate (GMS).” NCT02036528 ↗ |
| Known as | Garamycin | “Gentamicin, Garamycin” NCT04140786 ↗ |
| Known as | Garamycin Sponge | “Garamycin Sponge (Gentamicin-Collagen sponge)” NCT01951768 ↗ |
| Known as | Gentamicin (gentamicin) | “Gentamicin (gentamicin)” NCT00596167 ↗ |
| Known as | Gentamicin Sulfate | “containing Type I bovine collagen and 50 mg of gentamicin sulfate (equivalent to 32.5 mg of gentamicin base)” NCT01951768 ↗11“AppliGel-G is a topically applied hydrogel formulation of gentamicin sulfate (GMS).” NCT02036528 ↗ “Gentamicin Sulfate Inj 20mg/2ml vial for injection” NCT03476941 ↗ “Gentamicin Sulfate, Topical” NCT05143164 ↗ “Drug: Gentamicin Sulfate” NCT03012191 ↗ |
| Known as | Gentamicin Sulphate | “delivers a consistent dose of fast-release antibiotics called Gentamicin Sulphate (2.0 mg/cm2).” NCT01667874 ↗ |
| Known as | Gentamicin topical gel | “The purpose of this study is to determine whether AppliGel-G (Gentamicin topical gel) plus oral Ciprofloxacin / Doxycycline are safe and effective in the treatment of mild to...” NCT02036528 ↗ |
| Known as | Gentamicin, Garamycin | “Gentamicin, Garamycin” NCT03012191 ↗ |
| Known as | Gentamicin-Collagen sponge | “The gentamicin-collagen sponge, a surgically implantable topical antibiotic, is currently approved in 54 countries.” PMID 20716738 ↗ Aug 20101“Garamycin Sponge (Gentamicin-Collagen sponge)” NCT01951768 ↗ |
| Known as | Gentamicins | “Drug: Gentamicins” NCT02379754 ↗ |
| Known as | gentamycin | “The aim of this study is to investigate whether topical aminoglycosides (Gentamycin) may be beneficial for the treatment of HHS patients carrying nonsense mutations by inducing...” NCT03492866 ↗16“mLDG (lidocaine 0.16mg/mL, dexamethasone 0.02mg/mL, and gentamycin 0.16mg/mL) dissolved in 0.9% saline solution was administered three times a day.” NCT02577393 ↗ “Patients with known allergy to one of the drugs may be treated with oral Gentamycin (2.5mg/KgX3/d) for 3 weeks instead of the allergenic drug.” NCT02033408 ↗ “Clindamycin 2700mg+gentamycin 240mg+ 250ml sterile saline solution i.v. once a day until clinical improvement” NCT02309346 ↗ “an impirical antibiotic (gentamycin 80 mg).” NCT03007225 ↗ “Clindamycin 600 mg + Gentamycin 2 mg/kg.” NCT04438655 ↗ “Gentamycin-80mg in 60ml sterile water” NCT04285320 ↗ |
| Known as | Gentamycin-Gentamicin | “Gentamycin-Gentamicin®” NCT02033408 ↗ |
| Known as | GMS | “AppliGel-G is a topically applied hydrogel formulation of gentamicin sulfate (GMS).” NCT02036528 ↗ |
| Known as | Hexamycin | “gentamycin 40 mg ("Hexamycin®"), solution” NCT03157388 ↗1“gentamycin 40 mg ("Hexamycin®")” NCT01633762 ↗ |
| Action | Restore | “gentamicin was shown to restore functional dystrophin in a mouse model of DMD.” NCT00005574 ↗ |
| Modality | Small molecule | “aminoglycoside antibiotics (gentamicin)” NCT00484055 ↗ |
| Route | Intravenous | “Gentamicin will be given intravenously (through a vein) once a day for 14 days.” NCT00005574 ↗ |
| Target | CFTR | “Suppression of stop mutations in the CFTR gene with parenteral gentamicin” NCT00376428 ↗ |